SARCOMA CONNECT has summarised highlights of the recent CTOS 2019 meeting for you, by Dr Rick Haas.

Rick L.M. Haas is a soft tissue sarcoma focused radiation-oncologist from the NKI-AVL in Amsterdam, the Netherlands,where he works for almost 25 years as a staff member of the Department of Radiotherapy. He is an active member of CTOS (Board of Directors 2015-2017), the EORTC-STBSG (President of the Local Treatment Subcommittee), and the Sarcoma Patients Euronet (SPAEN) Patient Advocacy Organization (Medical Advisory Board).He is also a member of the Board of EMSOS and a Faculty Member of the ESMO initiated World Sarcoma Network. His current research interests focus mainly on sarcomas where he has initiated several clinical phase I (NCT01985295), II (NCT02575066, NCT02106312) and III trials (NCT01344018).Dr Rick Haashas authored or co-authored over 100 scientific papers as well as contributed to several books on sarcomas and lymphomas.
Programme summary
  • clock Duration 5 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
SARCOMA CONNECT

SARCOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Karyopharm Therapeutics.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update

Episode

3

of 3

episode
Oncology 
How are new data shaping the landscape in HER2-mutant NSCLC?

Insights from WCLC 2026

Experts
Dr Joshua Sabari
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2026

Educational programme supported by an Independent Educational Grant from Bayer.
conference-update Conference update
Oncology Hemato-oncology 
Myelofibrosis: Navigating unmet needs and overcoming clinical challenges

Expert perspectives on clinical trial highlights from EHA 2026

Experts
Prof. Francesco Passamonti, Prof. Claire Harrison
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Sep 2026

Brought to you by COR2ED Medical Affairs in collaboration with Menarini Stemline. This programme is intended for HCPS outside the UK. MED---2600258